TraceLink Continues Rapid Growth and Completes Transformation into Platform Company in 2024

January 17, 2025 04:33 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

BOSTON, Jan. 17, 2025 /PRNewswire/ -- TraceLink, the only no-code network digitalization platform for intelligent orchestration of the supply chain, today announced a landmark year of customer growth and groundbreaking product innovation. Fueled by the rapid adoption of end-to-end supply chain orchestration solutions on OPUS, the Orchestration Platform for Universal Solutions, TraceLink and its expanding ecosystem of partners are poised to redefine the future of digital supply chain transformation in Healthcare, Life Sciences, and beyond.

Customer & Network Ecosystem Growth Through Platform Excellence 

In 2024, TraceLink recorded explosive growth across its global customer base and trading partner network, adding 231 new customers, including 50 competitive winbacks for global track-and-trace orchestration and 43 new customers for Multienterprise Information Network Tower (MINT) in the solution's first calendar year of general availability. This commercial success was spurred by significant OPUS platform innovation, including the introduction of the industry's only no-code, drag-and-drop capabilities that enable business users to configure multienterprise supply chain solutions and end-to-end supply chain reports and dashboards. These capabilities, combined with the introduction of an AI assistant and a fully open ecosystem for certified Solution Partners and Technology Partners, are enabling TraceLink customers to radically accelerate strategic end-to-end supply chain digitalization programs with their trading partner networks.

"2024 has been a transformative year for TraceLink as customer adoption of MINT on OPUS has seen more than forty new Life Sciences and Healthcare companies signing up to accelerate their supply chain digitalization journeys. These innovative first-movers operate supply chains across multiple product classes, are headquartered in more than a dozen countries, come from four different segments across the end-to-end supply chain, and are pursuing orchestration use cases spanning External Manufacturing, Direct Supply Management, Logistics, Transportation, and Commerce," said Shabbir Dahod, President & CEO of TraceLink. "In 2025, the market should expect further innovation from TraceLink, including the release of AI-powered supply chain orchestration agents which will accelerate customers' business performance using the growing volume of real-time, end-to-end supply chain transactions and track-and-trace orchestration data flowing through the TraceLink Network."

TraceLink Completes Transformation Into a Platform Company

Based on the benefits that TraceLink derives from using the OPUS platform's no-code digitalization tools with a growing ecosystem of certified partners, TraceLink has restructured its global team to serve its customers more effectively as a platform company. This strategic organizational evolution reflects TraceLink's enhanced ability to scale, enabling the company to serve 10-100 times more customers and their trading partners while delivering richer capabilities that empower the orchestration of all business processes in pursuit of end-to-end supply chain digitalization. By advancing end-to-end digitalization—a critical prerequisite in creating the real-time data needed for leveraging AI and machine learning—TraceLink and its partner ecosystem are driving the future of supply chain management, strengthening its leadership in AI-driven supply chain intelligence, and continuing to lead the market in serving the regulatory compliance and global track-and-trace needs of TraceLink's more than 1,750+ customers.

For media inquiries, please contact: Erica Burns ([email protected]).

About TraceLink 

TraceLink Inc. is the largest end-to-end intelligent supply chain platform for life sciences and healthcare, enabling end-to-end orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network. Leading businesses trust TraceLink to deliver complete global connectivity, visibility, and traceability of healthcare products, ensuring that every patient gets the medicines they need when needed, safely and securely. To learn more, visit www.tracelink.com.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.